Resveratrol modulates autophagy and apoptosis via the SIRT1 and JNK signaling pathways, suppresses HSCs activation, and attenuates liver fibrosis in NAFLD. Here, SIRT1 is linked to metabolic dysfunction-associated steatotic liver disease.